Effect of frailty as measured by functional impairment on long-term outcomes in liver transplantation in the United States
- PMID: 40535479
- PMCID: PMC11886294
- DOI: 10.5500/wjt.v15.i2.98228
Effect of frailty as measured by functional impairment on long-term outcomes in liver transplantation in the United States
Abstract
Background: In patients with chronic liver disease or hepatic dysfunction with sarcopenia, there is an increased risk of frailty as measured by functional impairment, making frailty a vital predictor of post-transplant mortality.
Aim: To investigate the effects of frailty on mortality after liver transplantation.
Methods: A retrospective review of post-transplant outcomes in liver transplant recipients assessed frailty using Karnofsky Performance Score. Data from the Scientific Registry of Transplant Recipients database for 37427 liver transplant recipients was used.
Results: Of 82.7% frail patients, 42.7% were severely frail and 40% were moderately frail (P < 0.001) at the time of transplantation. Compared with non-frail patients, post-transplant mortality in frail patients was significantly higher at 12 months [odds ratio (OR) = 1.94, P = 0.02)]. Secondary analysis of the data revealed that liver grafts from donation after circulatory death (DCD) were more likely to be associated with frail patients at transplant (OR = 1.86, P < 0.001). Furthermore, a donor history of hypertension was associated with a lower likelihood of frailty in the recipient at the time of transplant (OR = 0.65, P = 0.03).
Conclusion: Recipient frailty is associated with increased mortality at 12 months following liver transplantation, and liver transplants from donors with DCD are associated with increased frailty of the liver transplant recipient.
Keywords: Alcohol-associated liver disease; Insulin resistance; Liver transplantation; Non-alcoholic steatohepatitis; Non-alcoholic steatotic liver disease; Oxidative stress.
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interests.
Figures


References
-
- Medscape Cirrhosis: Practice Essentials, Overview, Etiology. 2021. Available from: https://emedicine.medscape.com/article/185856-overview?form=fpf .
-
- Cuende N, Miranda B, Cañón JF, Garrido G, Matesanz R. Donor characteristics associated with liver graft survival. Transplantation. 2005;79:1445–1452. - PubMed
-
- Lai JC, Sonnenday CJ, Tapper EB, Duarte-Rojo A, Dunn MA, Bernal W, Carey EJ, Dasarathy S, Kamath BM, Kappus MR, Montano-Loza AJ, Nagai S, Tandon P. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant. 2019;19:1896–1906. - PMC - PubMed
-
- Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156. - PubMed
LinkOut - more resources
Full Text Sources